Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Janus Kinase Inhibitor [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
TOFACITINIB 155,647 7,847 5.0% 21,976 4,957 57.6 yrs 81.6%
RUXOLITINIB 68,133 10,908 16.0% 14,461 1,288 59.7 yrs 48.8%
UPADACITINIB 65,656 2,406 3.7% 15,931 636 57.4 yrs 71.2%
BARICITINIB 8,108 717 8.8% 2,498 477 58.2 yrs 67.9%
ABROCITINIB 3,170 57 1.8% 329 49 48.5 yrs 53.9%

Head-to-Head Comparisons

TOFACITINIB vs RUXOLITINIB TOFACITINIB vs UPADACITINIB TOFACITINIB vs BARICITINIB TOFACITINIB vs ABROCITINIB RUXOLITINIB vs UPADACITINIB RUXOLITINIB vs BARICITINIB RUXOLITINIB vs ABROCITINIB UPADACITINIB vs BARICITINIB UPADACITINIB vs ABROCITINIB BARICITINIB vs ABROCITINIB
← Back to Janus Kinase Inhibitor [EPC] Class side effects →